CPT® Code 0534T

Code Deleted. See 95999.

Official Description

Continuous recording of movement disorder symptoms, including bradykinesia, dyskinesia, and tremor for 6 days up to 10 days; set-up, patient training, configuration of monitor

Common Language Description

The CPT® Code 0534T refers to the continuous recording of movement disorder symptoms, specifically targeting conditions such as bradykinesia, dyskinesia, and tremor. Bradykinesia is characterized by a slow or decreased movement, while dyskinesia involves abnormal involuntary movements. Tremor, on the other hand, is defined as shakiness that occurs with voluntary movement, often observed in the hands and head. These symptoms are commonly associated with neurological disorders, particularly Parkinson’s Disease. The continuous recording process is essential for measuring the severity of these symptoms and understanding the proportion of time patients experience varying levels of dyskinesia, bradykinesia, and tremors in relation to their levodopa medication schedule. This procedure provides objective data that can help clinicians establish the necessity for advanced treatment options and identify patients who may be at risk for impulse control disorders (ICD), excessive daytime sleepiness, and immobility. The recording device used in this procedure is designed to be waterproof and resembles a clock. It is programmed to align with the patient's medication times and is worn on the wrist, ensuring a snug fit against the skin. The device is activated by placing a finger on its face, and it vibrates at pre-set medication times to remind the patient to take their medication. After taking the medication, the patient indicates completion by sweeping a finger over the clock face. At the conclusion of the designated recording period, which lasts between 6 to 10 days, the device displays an envelope symbol, signaling the patient to switch it off by placing a finger on the clock face. The device is then removed from the wristband and either mailed or hand-delivered to the clinician. The clinician subsequently uploads the recorded data into a specialized software program for analysis, generating a comprehensive report. This report is reviewed and interpreted by the clinician, who may then make necessary adjustments to the patient's treatment plan based on the findings. It is important to note that while Code 0534T covers the set-up, patient training, and configuration of the monitor, other related codes exist for different aspects of the procedure, ensuring comprehensive billing for all components involved in the continuous monitoring of movement disorder symptoms.

1. Indications

The continuous recording of movement disorder symptoms using CPT® Code 0534T is indicated for patients exhibiting symptoms associated with various neurological conditions. The specific indications include:

Bradykinesia - This condition is characterized by a noticeable reduction in movement speed and amplitude, often impacting daily activities and overall quality of life.
Dyskinesia - Patients may experience abnormal involuntary movements that can be distressing and disruptive, often occurring as a side effect of long-term dopaminergic therapy.
Tremor - The presence of tremors, which are involuntary shaking movements typically observed in the hands and head, can significantly affect a patient's ability to perform tasks.
Monitoring Treatment Efficacy - The procedure is also indicated for assessing the effectiveness of levodopa medication in managing symptoms, allowing for timely adjustments to treatment regimens.
Identifying Risks - Continuous monitoring can help identify patients at risk for impulse control disorders (ICD), excessive daytime sleepiness, and immobility, which are critical for comprehensive patient management.

2. Procedure

The procedure for continuous recording of movement disorder symptoms involves several key steps, which are detailed as follows:

Step 1: Device Preparation - A waterproof recording device, resembling a clock, is programmed to align with the patient's medication schedule. This ensures that the device can accurately capture data related to the timing of medication intake.
Step 2: Patient Training - The clinician provides training to the patient on how to use the device effectively. This includes instructions on how to activate the device, respond to medication reminders, and indicate when medication has been taken.
Step 3: Device Application - The device is inserted into a band and placed on the patient's wrist, ensuring a snug fit against the skin for optimal data collection. The clinician ensures that the device is securely fastened and positioned correctly.
Step 4: Data Recording - Once the device is activated by placing a finger on the clock face, it begins continuous recording of the patient's movement disorder symptoms over a period of 6 to 10 days. The device vibrates at pre-set medication times to remind the patient to take their medication.
Step 5: Data Submission - At the end of the recording period, the device displays an envelope symbol, indicating that the patient should switch it off. The device is then removed from the wristband and either mailed or hand-delivered to the clinician for data analysis.
Step 6: Data Analysis - The clinician uploads the recorded data into a specialized software program for analysis. This step is crucial for generating a comprehensive report that details the patient's movement disorder symptoms in relation to their medication regimen.
Step 7: Treatment Adjustment - Finally, the clinician reviews and interprets the data, using the insights gained to make informed adjustments to the patient's treatment plan as necessary.

3. Post-Procedure

After the continuous recording procedure is completed, the patient may experience a brief period of adjustment as their treatment regimen is modified based on the data analysis. The clinician will provide guidance on any changes to medication or therapy that may be required. Follow-up appointments may be scheduled to monitor the patient's response to the adjusted treatment plan and to ensure that symptoms are being effectively managed. It is essential for patients to maintain open communication with their healthcare provider regarding any new or worsening symptoms that may arise following the procedure. Additionally, the clinician may discuss the importance of ongoing monitoring and potential future assessments to ensure optimal management of the movement disorder.

Short Descr	CONT REC MVMT DO SETUP&TRAIN
Medium Descr	CONT REC MVMT DO SX 6 D<10 D SETUP & PT TRAING
Long Descr	Continuous recording of movement disorder symptoms, including bradykinesia, dyskinesia, and tremor for 6 days up to 10 days; set-up, patient training, configuration of monitor
Status Code	Carriers Price the Code
Global Days	XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC)	1 - Diagnostic Tests for Radiology Services
Multiple Procedures (51)	9 - Concept does not apply.
Bilateral Surgery (50)	9 - Concept does not apply.
Physician Supervisions	09 - Concept does not apply.
Assistant Surgeon (80, 82)	9 - Concept does not apply.
Co-Surgeons (62)	9 - Concept does not apply.
Team Surgery (66)	9 - Concept does not apply.
Diagnostic Imaging Family	99 - Concept Does Not Apply
APC Status Indicator	STV-Packaged Codes
Berenson-Eggers TOS (BETOS)	none
MUE	Not applicable/unspecified.